These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 8187625)
1. [Secondary leukemias after etoposide chemotherapy]. Bokemeyer C; Schmoll HJ; Poliwoda H Dtsch Med Wochenschr; 1994 May; 119(19):707-13. PubMed ID: 8187625 [No Abstract] [Full Text] [Related]
2. [Chemotherapy of small cell bronchogenic carcinoma in a patient on hemodialysis for chronic renal failure. Apropos of a case]. Guillou B; Robinet G; Gouva S; Guillodo MP; Daniel C; Clavier J Rev Pneumol Clin; 1998 Sep; 54(4):215-8. PubMed ID: 9805752 [TBL] [Abstract][Full Text] [Related]
3. Etoposide--an effective single drug for treating bronchogenic carcinoma. Anderson G; Peel ET; Cheong CM; Broderick NJ Clin Oncol; 1982; 8(3):215-8. PubMed ID: 7140048 [No Abstract] [Full Text] [Related]
4. Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma. Cohen MH; Broder LE; Fossieck BE; Ihde DC; Minna JD Cancer Treat Rep; 1977; 61(3):489-90. PubMed ID: 194694 [No Abstract] [Full Text] [Related]
6. Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer. Bokemeyer C; Schmoll HJ; Kuczyk MA; Beyer J; Siegert W J Natl Cancer Inst; 1995 Jan; 87(1):58-60. PubMed ID: 7666466 [No Abstract] [Full Text] [Related]
7. Phase II studies on weekly cisplatinum plus epirubicin or etoposide in the treatment of advanced non-small cell bronchogenic carcinoma. Lelli G; Casadio M; Giuliotti C; Giordani S; Martoni A; Strocchi E; Pannuti F Chemioterapia; 1986 Aug; 5(4):228-31. PubMed ID: 3021346 [TBL] [Abstract][Full Text] [Related]
8. Current status of American studies with bleomycin. Carter SK; Blum RH Prog Biochem Pharmacol; 1976; 11():158-71. PubMed ID: 63960 [No Abstract] [Full Text] [Related]